p27 and cyclin E/D2 associations in testicular germ cell tumors: Implications for tumorigenesis

Applied Immunohistochemistry and Molecular Morphology

Volumn 11, Issue 2, 2003, Pages 138-143

  Kukoski, Robyn ^a   Blonigen, Brian ^a   Macri, Ettore ^d   Renshaw, Andrew A ^b   Hoffman, Michael ^c,d   Loda, Massimo ^c,d   Datta, Milton W ^a,c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b BAPTIST HOSPITAL OF MIAMI   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Cell cycle; Cyclins; Germ cell tumor; p27; Testis

Indexed keywords

CYCLIN D2; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; PROTEIN P27;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CHROMOSOME 12P; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYONAL CARCINOMA; GENE ACTIVATION; GENE AMPLIFICATION; GENE LOCATION; GENE OVEREXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TUMOR CELL;

EID: 0038575214     PISSN: 15412016     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129039-200306000-00008     Document Type: Article

References (38)

1. Ulbright TM. Germ cell neoplasms of the testis. Am J Surg Pathol. 1993;17:1075-91.
2. Sherr CJ. Cancer cell cycles. Science. 1996;274:1672-7.
3. Datta MW, Renshaw AA, Dutta A, et al. Evaluation of cyclin expression in testicular germ cell tumors: cyclin E correlates with tumor type, advanced clinical stage, and pulmonary metastasis. Mod Pathol. 2000;13:667-72.
4. Cheng M, Sexl V, Sherr CJ, et al. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci U S A. 1998;95:1091-6.
5. Cheng M, Olivier P, Diehl JA, et al. The p21(Cip1) and p27(Kip1) CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 1999;18:1571-83.
6. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 2000;60:3689-95.
7. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med. 1997;3:231-4.
8. Blain SW, Montalvo E, Massague J. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J Biol Chem. 1997;272:25863-72.
9. Cariou S, Catzavelos C, Slingerland JM. Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1. Breast Cancer Res Treat. 1998;52:29-41.
10. Macri E, Loda M. Role of p27 in prostate carcinogenesis. Cancer Metastasis Rev. 1998;17:337-44.
11. Nakasu S, Nakajima M, Handa J. Anomalous p27kip1 expression in a subset of malignant gliomas. Brain Tumor Pathol. 1999;16:17-21.
12. Sanchez-Beato M, Camacho FI, Martinez-Montero JC, et al. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression: p27/KIP1-cyclin D3 colocalization in tumor cells. Blood. 1999;94:765-72.
13. Bales ES, Dietrich C, Bandyopadhyay D, et al. High levels of expression of p27KIP1 and cyclin E in invasive primary malignant melanomas. J Invest Dermatol. 1999;113:1039-46.
14. Sherr CJ. D-type cyclins. Trends Biochem Sci. 1995;20:187-90.
15. Kato JY. Control of G1 progression by D-type cyclins: key event for cell proliferation. Leukemia. 1997;11(suppl 3):347-51.
16. Sicinski P, Donaher JL, Geng Y, et al. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature. 1996;384:470-4.
17. de Boer CJ, van Krieken JH, Kluin-Nelemans HC, et al. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene. 1995;10:1833-40.
18. Buschges R, Weber RG, Actor B, et al. Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas. Brain Pathol. 1999;9:435-42; discussion 432-3.
19. Jiang W, Kahn SM, Tomita N, et al. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res. 1992;52:2980-3.
20. Bartkova J, Rajpert-de Meyts E, Skakkebaek NE, et al. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy. J Pathol. 1999;187:573-81.
21. Houldsworth J, Reuter V, Bosl GJ, et al. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Cell Growth Differ. 1997;8:293-9.
22. van Echten J, van Gurp RJ, Stoepker M, et al. No recurrent structural abnormalities apart from i(12p) in primary germ cell tumors of the adult testis. Genes Chromosomes Cancer. 1995;14:133-44.
23. Meng FJ, Zhou Y, Giwercman A, et al. Fluorescence in situ hybridization analysis of chromosome 12 anomalies in semen cells from patients with carcinoma in situ of the testis. J Pathol. 1998;186:235-9.
24. Looijenga LH, Oosterhuis JW. Pathogenesis of testicular germ cell tumors. Rev Reprod. 1999;4:90-100.
25. Bosl GJ, Ilson DH, Rodriguez E, et al. Clinical relevance of the i(12p) marker chromosome in germ cell tumors. J Natl Cancer Inst. 1994;86:349-55.
26. Bosl GJ, Dmitrovsky E, Reuter VE, et al. Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors [published erratum appears in J Natl Cancer Inst. 1990;82:627] J Natl Cancer Inst. 1989;81:1874-8.
27. Malek NP, Casper J, Looijenga LH, et al. Quantification of additional short arms of chromosome 12 in germ cell tumors using the polymerase chain reaction. Eur J Cancer. 1997;33:1488-94.
28. Suijkerbuijk RF, Sinke RJ, Meloni AM, et al. Overrepresentation of chromosome 12p sequences and karyotypic evolution in i(12p)negative testicular germ-cell tumors revealed by fluorescence in situ hybridization. Cancer Genet Cytogenet. 1993;70:85-93.
29. Mostert MM, van de Pol M, van Echten J, et al. Fluorescence in situ hybridization-based approaches for detection of 12p overrepresentation, in particular i(12p), in cell lines of human testicular germ cell tumors of adults. Cancer Genet Cytogenet. 1996;87:95-102.
30. Baldassarre G, Bellitti B, Bruni P, et al. Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells. J Clin Invest. 1999;104:865-74.
31. Datta MW, Macri E, Signoretti S, et al. Loss of p21 expression is associated with the onset of mdm-2 expression and the development of invasive testicular germ cell tumors. Mod Pathol. 2001;14:437-442.
32. Guillou L, Estreicher A, Chaubert P, et al. Germ cell tumors of the testis overexpress wild-type p53. Am J Pathol. 1996;149:1221-8.
33. Bartkova J, Thullberg M, Rajpert-De Meyts E, et al. Cell cycle regulators in testicular cancer: loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumors. Int J Cancer. 2000;85:370-5.
34. Han EK, Lim JT, Arber N, et al. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. Prostate. 1998;35:95-101.
35. Keum JS, Kong G, Yang SC, et al. Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer. Br J Cancer. 1999;81:127-32.
36. Takano Y, Takenaka H, Kato Y, et al. Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity. J Cancer Res Clin Oncol. 1999;125:505-12.
37. Sutherland RL, Musgrove EA. Cyclin E and prognosis in patients with breast cancer. N Engl J Med. 2002;347:1546-7.
38. Keyomarsi K, Tucker SL, Buchholz TA, et al. Cyclin E and survival in patients with breast cancer. N Engl J Med. 2002;347:1566-75.